BullFrog AI Holdings (BFRG) FCF Margin (2023 - 2025)
BullFrog AI Holdings' (BFRG) quarterly FCF Margin came in at 1327.34% in Q3 2025, up 69.17% quarter-over-quarter from 4305.78% in Q2 2025.
Powered by 
Analysis
BullFrog AI Holdings (BFRG) FCF Margin (2023 - 2025) Analysis & Trends
BullFrog AI Holdings (BFRG) has reported FCF Margin for 2 consecutive years, with 1327.34% the latest figure, recorded in Q3 2025.
- For the quarter ending Q3 2025, FCF Margin changed N/A year-over-year to 1327.34%; the trailing twelve-month figure through Dec 2025 stood at 4733.23% (changed N/A YoY), and the FY2025 full-year result was 4733.23%, changed N/A from the prior year.
- FCF Margin improved to 1327.34% in Q3 2025 per BFRG's latest filing, from 4305.78% in the prior quarter.
- Across five years, FCF Margin topped out at 1327.34% in Q3 2025 and bottomed at 4305.78% in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | 34.70% |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | 44.00% |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | 30.39% |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | 13.35% |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | - |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | -388.28% |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | 22.62% |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | 14.91% |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | -22.35% |
| 10 | BullFrog AI Holdings | 9.27 Mn | 2.35 Mn | 106,899.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -1,327.34% |
| Jun 30, 2025 | -4,305.78% |
| Sep 30, 2023 | -2,144.26% |